Skip to content

Clinical trials

Lymphoma, Non-Hodgkin trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Country / region: Switzerland Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20053
20065
20072
20081
20101
20111
20122
20141
20174
20182
20195
20215
20222
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Active, not recruiting6
Terminated4
Unknown status4
Recruiting4
No longer available1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute5
European Organisation for Research and Treatment of Cancer - EORTC4
Hoffmann-La Roche4
Loxo Oncology, Inc.4
Bayer2
Bristol-Myers Squibb2
Celgene2
Genmab2
German High-Grade Non-Hodgkin's Lymphoma Study Group2
Gilead Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin48
Lymphoma, Follicular19
Lymphoma15
Lymphoma, Large B-Cell, Diffuse15
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, Mantle-Cell12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Large-Cell, Immunoblastic11
Burkitt Lymphoma10

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.